Yoga may ease breathing and boost daily life in bronchiectasis patients
NCT ID NCT04744220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether a structured yoga program (including breathing exercises, relaxation, and postures) can improve functional capacity and quality of life in adults aged 30-55 with bronchiectasis. 60 participants were enrolled. The study measured shortness of breath and other outcomes to see if yoga offers benefits beyond standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Yoga training program (breathing exercises, relaxation, postures)
- What this could lead to
- If successful, yoga could become a supportive therapy to help people with bronchiectasis breathe easier and feel better day-to-day.
- What could go wrong
- This is a small, completed trial without a control group, so results may not be definitive. Yoga is generally safe but may not benefit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with bronchiectasis * Age 30-55 * Not having a known systemic, orthopedic or neurological disease Exclusion Criteria: * Severe heart failure * People who had an acute exacerbation up to three weeks ago will not be included in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Medipol University Hospital
Istanbul, 34000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mapping patient profiles unlock better breathing therapy for bronchiectasis?
- Can an inhaled drug ease bronchiectasis? a trial seeks answers
- Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?
- Could your own lung cells heal damaged airways? a new trial aims to find out
- New drug CTX-187 takes aim at stubborn bacterial infections
- Lung patients may soon do rehab from home via app